Minakem Generic APIs Minakem Generic APIs

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Ajanta Pharma Limited

    Client Virtual Booth

    AJANTA PHARMA LIMITED

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Ajanta Pharma Limited
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    98, Ajanta House, Charkop, Kandivili (West) Mumbai, 400 067, India
    Telephone
    Telephone
    91 22 6606 1000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.ajantapharma.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Ajanta Pharma's Generic Paliperidone Receives Approval in US
    Ajanta Pharma's Generic Paliperidone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218514

    FDA
    26 Jun 2024
    Share Share
    Ajanta Pharma's Generic Prochlorperazine Maleate Receives Approval in the U.S
    Ajanta Pharma's Generic Prochlorperazine Maleate Receives Approval in the U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218515

    FDA
    09 May 2024
    Share Share
    Ajanta Pharma posts Q4 FY24 consolidated PAT at Rs. 202.72 Cr
    Ajanta Pharma posts Q4 FY24 consolidated PAT at Rs. 202.72 Cr

    https://www.indianpharmapost.com/news/ajanta-pharma-posts-q4-fy24-consolidated-pat-at-rs-20272-cr-15601

    INDINPHARMAPOST
    04 May 2024
    Share Share
    Ajanta Pharma's Generic Varenicline Tartrate Receives Approval in the U.S
    Ajanta Pharma's Generic Varenicline Tartrate Receives Approval in the U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213019

    FDA
    19 Mar 2024
    Share Share
    Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.
    Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217659

    FDA
    23 Feb 2024
    Share Share
    Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr
    Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr

    https://www.indianpharmapost.com/news/ajanta-pharma-posts-q2-fy24-consolidated-pat-at-rs-19530-cr-14846

    INDIAN PHARMA POST
    01 Nov 2023
    Share Share
    Ajanta Pharma's Generic Topiramate Receives Approval in the U.S.
    Ajanta Pharma's Generic Topiramate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215663

    FDA
    15 Aug 2023
    Share Share
    Ajanta Pharma looks to expand ops in high-growth Asian, African geographies
    Ajanta Pharma looks to expand ops in high-growth Asian, African geographies

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ajanta-pharma-looks-to-expand-ops-in-high-growth-asian-african-geographies/articleshow/101430242.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    02 Jul 2023
    Share Share
    Ajanta Pharma gets US FDA observations after inspection at Dahej facility
    Ajanta Pharma gets US FDA observations after inspection at Dahej facility

    https://www.livemint.com/companies/news/ajanta-pharma-gets-us-fda-observations-after-inspection-at-dahej-facility-11687746308354.html

    LIVEMINT
    26 Jun 2023
    Share Share
    Ajanta's Generic Pantoprazole Sodium Receives Approval in the U.S.
    Ajanta's Generic Pantoprazole Sodium Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217416

    FDA
    09 Feb 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    bora-pharmaceuticals-2024-07-01

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search